Collegium Pharmaceutical competitors

Collegium Pharmaceutical's competitors include Depomed, Inovio Pharmaceuticals, Vertex Pharmaceuticals and MyoKardia
Add company...
Collegium Pharmaceutical
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Depomed
Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Founding Date
Founding Date
2002
Founding Date
1995
Founding Date
1979
Founding Date
1989
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Canton, US HQ
Locations
Newark, US HQ
Locations
Blue Bell, US HQ
San Diego, US
San Diego, US
Locations
Boston, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
234
Employees
490
Employees
239
Employees
2,3007% increase
Employees
1024% increase
Valuation ($)
Valuation ($)
879.6 m
Valuation ($)
465.5 m
Valuation ($)
385.7 m
Valuation ($)
40.6 b
Valuation ($)
1.7 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
7 k
Twitter followers
32.9 k
Twitter followers
387

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$380.7m (FY, 2017)
Revenue (est.)
$42.2m (FY, 2017)
Revenue (est.)
$2.5b (FY, 2017)
Revenue (est.)
$22.5m (FY, 2017)
Net income
Net income
($74.9m) (FY, 2017)
Net income
($102.5m) (FY, 2017)
Net income
($88.2m) (FY, 2017)
Net income
$91.6m (FY, 2017)
Net income
($46m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 106m
Total funding raised
$ 875m
Total funding raised
$ 63.3m
Total funding raised
$ 2.4m
Total funding raised
$ 98m
For sources of this data, please see the company profileDownload Excel

View company profiles

Depomed
HQ
Newark, US
Employees
490

Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.

View company
Inovio Pharmaceuticals
HQ
Blue Bell, US
Employees
239

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
Vertex Pharmaceuticals
HQ
Boston, US
Employees
2,300↑ 7% increase

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company